Emma was diagnosed with SMA in 2024, while Bartosz received his diagnosis three years earlier, in 2021. Both children were diagnosed late, which has led to significant mobility issues that they will likely face for life. This late diagnosis is not just a personal tragedy for the Nelson family; it reflects a broader systemic issue in the UK, where an estimated 33 babies each year may need a wheelchair due to similar late diagnoses of SMA.

In response to the growing awareness of SMA’s impact, the Scottish government has announced that all babies will now be screened for SMA as part of the NHS newborn blood spot test. This move is crucial, as early intervention can significantly alter the course of the disease. Emma and Bartosz were fortunate to receive the gene therapy Zolgensma through the NHS, a treatment that can halt the progression of SMA and potentially eradicate it if administered early enough.

What the data shows

The UK currently stands as a global outlier regarding newborn SMA screening, lagging behind 46 countries, including the United States and nearly three-quarters of Europe, where such screening is already in place. The projected rollout year for SMA screening in England is 2031, leaving many families like the Nelsons to navigate the complexities of late diagnosis and treatment in the interim.

Jesy Nelson’s experience is echoed by other families facing similar struggles. Paola and Rhys Davie, who also have children with SMA, expressed their solidarity, stating, “We know how you feel,” and “I’m sorry you’re going through this. I remember how overwhelming it felt at the beginning.” Their words resonate deeply within the SMA community, highlighting the emotional toll of navigating such a diagnosis.

Paola poignantly remarked, “It’s awful to think that if I’d decided to give birth in Italy, we probably wouldn’t be having this conversation,” emphasizing the disparities in healthcare systems across countries. The sentiment reflects a growing frustration among families advocating for better healthcare policies and practices in the UK.

As Emma and Bartosz continue their journey, their family remains hopeful. Rhys Davie shared, “Any moment like that when we can see she’s become stronger is incredible – we just feel so much gratitude and joy.” This sentiment captures the essence of resilience in the face of adversity, as families rally together to advocate for necessary changes in healthcare.

While the future of SMA screening in the UK looks promising, many uncertainties remain. Details remain unconfirmed regarding the exact timeline and implementation of these screening measures. However, the Nelson family’s story serves as a powerful reminder of the importance of early diagnosis and intervention, not just for twins like Emma and Bartosz but for all children at risk of SMA.

The post Twins and the Challenge of Spinal Muscular Atrophy: A Family’s Journey appeared first on casinoca.

Just five months ago, the Forrester family received the devastating news that their two-year-old daughter, Leni, had been diagnosed with Sanfilippo disease, a rare genetic disorder often referred to as childhood dementia. This condition progressively damages the brain, leading to a heartbreaking decline in cognitive and physical abilities. As Leni’s parents, Emily and Gus Forrester, grapple with this diagnosis, they find themselves in a race against time to secure treatment for their daughter.

Sanfilippo disease is characterized by an enzyme deficiency that prevents the body from breaking down certain molecules, resulting in irreversible damage that typically begins around the age of three. Children diagnosed with this condition often lose their ability to walk, talk, eat, and drink, leading to a tragic decline in their quality of life. With no approved treatments or cures currently available in the UK, the Forrester family faces an uphill battle.

Emily Forrester has openly shared the emotional turmoil of receiving such a diagnosis, stating, “It is every parent’s worst nightmare.” The couple’s dreams for Leni’s future have been shattered, as they confront the grim reality of her condition. Emily poignantly noted, “All your dreams for your child’s future are taken away.” This sentiment resonates deeply with many families affected by childhood dementia, as they navigate the complexities of care and treatment.

The statistics are alarming: around 240 children born in the UK each year are affected by childhood dementia, with Sanfilippo disease being one of the most severe forms. The Forrester family is not alone in their struggle; they represent a growing community advocating for better awareness and funding for research into potential treatments. They believe that early intervention is crucial, as Emily emphasized, “Early treatment is key for these children. The damage cannot be reversed once it’s done.” This urgency underscores the need for immediate action in the face of such a devastating diagnosis.

In their quest for a solution, the Forresters are advocating for government funding to support research into clinical trials for potential treatments. Professor Brian Bigger has developed a gene therapy approach aimed at addressing childhood dementia, offering a glimmer of hope for families like the Forresters. However, the path to securing funding and initiating clinical trials is fraught with challenges, and the family remains determined to push for progress.

As they navigate this difficult journey, the Forrester family is also calling for newborn screening to facilitate earlier detection of rare genetic conditions like Sanfilippo disease. Such measures could lead to timely interventions and improve the prognosis for affected children. The couple’s advocacy highlights the importance of awareness and the need for systemic changes in how rare diseases are approached in the healthcare system.

The Forrester family’s fight for Leni is not just a personal battle; it reflects a broader issue faced by many families dealing with childhood dementia. The emotional and physical toll of watching a child decline is unimaginable, and the urgency for treatment cannot be overstated. As they continue their advocacy, the Forresters hope to inspire others to join their cause and bring attention to the pressing need for research and funding in the realm of childhood dementia.

In a poignant reminder of the stakes involved, Emily Forrester stated, “If we can’t get treatment, she will suffer the most awful physical and mental decline you can imagine and then die in her early to mid-teens.” This stark reality serves as a call to action for policymakers, researchers, and the public to recognize the importance of addressing childhood dementia and supporting families like the Forresters in their fight for a better future for their children.

The post Childhood dementia: The Heartbreaking Reality of : Leni Forrester’s Fight Against Sanfilippo Disease appeared first on casinoca.